Urologic Oncology Program
The Division of Urologic Oncology at The Cancer Institute of New Jersey provides highly specialized care for patients with tumors of the genitourinary (GU) tract. Our physicians have specialized clinical and research interest in tumors of the prostate, testis, kidney, and bladder.
CINJ is a leader in laparoscopic renal procedures and has extensive experience with robotic prostatectomy. The major advantages of robotic prostatectomy include shorter hospital stays, lower blood loss, and faster recovery. Given that robotic surgery is a relatively new technology, surgeon experience is critical for good outcome. The Cancer Institute of New Jersey has developed a center of excellence for robotic surgery and its urologic oncologists have performed more than 1,000 robotic prostatectomies over the last five years. Dr. Isaac Kim has also developed a new surgical technique for nerve sparing (Athermal Intrafascial Robotic Prostatectomy or AIR prostatectomy) using the robot that leads to faster recovery of sexual function as well as bladder control.
The Division of Urologic Oncology offers a wide breadth of clinical trials for patients with tumors of the genitourinary tract. In addition, the Dean and Betty Gallo Prostate Cancer Center provides a hub for basic and clinical research in prostate cancer as well as a forum for prostate cancer outreach activities.
Clinical Trials:
Useful Links From The Resource and Learning Center:
Staff of this Program:
Isaac Kim, MD, PhD, Chief of Urologic Oncology
Robert DiPaola, MD, Medical Oncologist
Thomas Jang, MD, Urologic Oncologist
Michael Karellas, MD, Urologic Oncologist
Tina Mayer, MD, Medical Oncologist
Eric A. Singer, MD, MA, Urologic Oncologist
Mark Stein, MD, Medical Oncologist
Robert Weiss, MD, Urologic Oncologist
Stephanie Matlin, RN, Nurse Clinician
Kathy Morris, RN, Nurse Clinician
Jennifer Bylina-Potts, Urologic Technician
Wasfi (Willie) Abu Al Huda, Urologic Technician
